These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7260778)

  • 1. Probucol and high-density-lipoprotein cholesterol.
    Gagné C; Lupien PJ; Brun D; Moorjani S; Toussaint M
    Can Med Assoc J; 1980 Sep; 123(5):356. PubMed ID: 7260778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins.
    Atmeh RF; Stewart JM; Boag DE; Packard CJ; Lorimer AR; Shepherd J
    J Lipid Res; 1983 May; 24(5):588-95. PubMed ID: 6875383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
    Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
    Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
    Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
    Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of high-density lipoprotein cholesterol in persons with hypertrigliceridemia-hyperlipoproteinemia type IV].
    Kusić M; Gavrilović M; Mihajlović M
    Srp Arh Celok Lek; 1982 Jun; 110(6):691-6. PubMed ID: 7170652
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
    Brook JG; Aviram M; Luboshitzky R; Barzilai D
    Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of inhalation exposure to phenolformaldehyde and melamine bitumens on HDL cholesterol levels in humans (author's transl)].
    Turay J; Beseda I; Bíresová A
    Cas Lek Cesk; 1981 Jun; 120(24):729-32. PubMed ID: 7296618
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum cholesterol and high density lipoprotein cholesterol in Nigerian diabetics.
    Aduba O; Onwuamaeze I; Oli J; Udeozo K
    East Afr Med J; 1984 Jan; 61(1):35-9. PubMed ID: 6745139
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia.
    Dachet C; Motta C; Neufcour D; Jacotot B
    Adv Exp Med Biol; 1988; 243():179-84. PubMed ID: 3223415
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of fluvastatin or bezafibrate on the distribution of high density lipoprotein subpopulations in patients with familial hypercholesterolemia.
    Hailer S; Pogarell O; Keller C; Wolfram G
    Arzneimittelforschung; 1996 Sep; 46(9):879-83. PubMed ID: 8876936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.